प्रोडक्ट्स
अन्य
March 7, 2022
bioLytical receives Health Canada authorization for its iStatis COVID-19 antigen test, helping Canadians identify active infections
August 31, 2021
bioLytical is one of BC's fastest-growing companies for the fifth year, recognizing its contributions to health technology
September 2, 2022
bioLytical named one of BC's fastest-growing companies for the sixth year, demonstrating ongoing innovation in health technology
March 27, 2023
bioLytical's INSTI Multiplex HIV-1/2 Syphilis Antibody Test gains Health Canada approval, boosting HIV and syphilis testing
October 18, 2022
bioLytical receives WHO prequalification for its iStatis COVID-19 antigen home test, allowing its immediate global market entry
October 21, 2022
bioLytical is listed as one of the top 100 tech and life sciences companies in BC, demonstrating ongoing commitment to innovation
March 20, 2022
bioLytical Laboratories Inc. receives CE Mark for its iStatis COVID-19 antigen home test, providing increased identification options
January 19, 2024
bioLytical donates HIV tests to support NGO Coalition Plus and International Testing Week to boost testing access worldwide
May 27, 2020
bioLytical receives funding to develop a 1-minute COVID-19 test to help detection efforts across the EU with its INSTI platform
April 1, 2022
bioLytical receives Health Canada authorization for the iStatis COVID-19 antigen home test, ensuring safe and reliable home testing
November 23, 2021
bioLytical receives Health Canada approval for its one-minute COVID-19 antibody rapid test, helping boost detection efforts
August 10, 2021
bioLytical hosted a visit from the Honourable Ravi Kahlon, who toured the new facilities and learned about their advancements
July 12, 2021
bioLytical receives CE Mark for the worlds first 1-minute Hepatitis C antibody test to help end HCV as a public health
July 20, 2021
bioLytical is pleased to anounce the appointment of Dr. Joshua Eades, Ph.D., as the Company's new Chief Scientific Officer
June 4, 2021
Learn about the I'm Ready Research program and its efforts to end HIV in Canada with its easy access to testing, care, and treatment
June 5, 2020
bioLytical's INSTI SARS-CoV-2 antibody test gains media attention, showcasing its detection capabilities for COVID-19 antibodies
Join the initiative to end HIV in Canada, working together to achieve zero new infections and better health outcomes
June 15, 2021
Understand the importance of COVID-19 antibody testing in a post-pandemic world ensuring immunity tracking and identification
July 24, 2018
bioLytical commends the launch of the MenStar Coalition to engage men in innovative ways to break the cycle of HIV transmission
Celebrate National HIV Testing Day 2021 with the theme "My Test, My Way," encouraging personalized and accessible HIV testing
September 19, 2019
The INSTI rapid HIV test is now available for expanded point-of-care use in Canada with quick accurate results in one minute
November 12, 2020
The INSTI HIV self-test is featured in Canadian news, showcasing its availability and impact on at-home HIV testing
August 22, 2019
Explore the history behind Canada's HIV self-test, highlighting the milestones in making at-home testing accessible
October 15, 2020
bioLytical announces the launch of the INSTI one-minute COVID-19 antibody test,helping Canada with its pandemic response
December 2, 2016
bioLytical introduces the INSTI HIV self-test to the Kenyan Regulated Pharmacy Network to boost testing access across the country
November 3, 2020
Health Canada approves Canada's first HIV self-test by bioLytical, providing increased options for HIV testing to all Canadians
November 27, 2018
The INSTI HIV self-test earns WHO prequalification for home testing, validating its quality, safety, and reliability for global use
May 4, 2017
bioLytical's INSTI HIV self-test receives Kenya Ministry of Health approval for safe and reliable at-home HIV testing in Kenya
July 28, 2017
bioLytical launches INSTI HIV home test in the Netherlands providing options for increase HIV testing across the country
December 1, 2016
HIV self-tests provide a crucial STI testing solution for people living outside urban areas increasing testing access
November 14, 2016
bioLytical launches the world's fastest HIV self-test in the UK, providing quick, easy-to-use, and accurate at-home testing
This World AIDS Day, bioLytical advocates for HIV prevention through self-testing in France promoting accessible rapid testing
July 27, 2017
A Kenyan study shows high user acceptance of the INSTI HIV self-test, showingg its effectiveness and reliability for at-home testing
July 15, 2016
Prince Harry raises awareness of HIV using the INSTI test showcasing the importance of regular testing in reducing HIV globally
October 27, 2016
bioLytical participates in the Glasgow HIV Drug Therapy Congress sharing insights and advancements in HIV treatment and testing
August 19, 2016
bioLytical announces U.S. patent filings for its Zika detection assays, expanding its growing intellectual property portfolio
February 21, 2017
bioLytical receives an innovative technology contract from Vizient for its rapid HIV test boosting testing across the US
April 24, 2017
bioLytical launches an instant HIV home test in Belgium, providing quick, accurate results and boosting testing access for Belgians
December 13, 2012
INSTI HIV test impresses attendees at the CDC HIV Diagnostics Conference showcasing its rapid and accurate testing capabilities
July 7, 2015
bioLytical to present its findings on early HIV detection, highlighting advancements in testing and early intervention strategies
August 6, 2015
bioLytical applauds Virginia Department of Health and Walgreens for increasing HIV testing sites, boosting testing access
February 16, 2015
bioLytical's INSTI HIV/Syphilis Multiplex Test receives clearance for the European market offering two results with one sample
October 29, 2014
bioLytical develops a 60-second Ebola test, offering rapid and accurate results to support quick diagnosis and outbreak management
February 24, 2015
bioLytical's INSTI HIV Test receives FDA approval for HIV-2, expanding testing options and improving detection of HIV-2 infections
July 11, 2016
bioLytical receives CE Mark for its HIV self-testing kit, affirming its quality and safety for at-home testing
March 22, 2016
bioLytical completes proof of concept on 60-second diagnostic tests for mosquito-borne diseases Zika, Dengue, and Chikungunya
September 3, 2015
The INSTI HIV test detects gp41-specific IgM antibodies, providing accurate and early detection of HIV infections
June 24, 2015
bioLytical Partners with Walgreens and Donates HIV Tests for National HIV Testing Day to help more Americans get tested
March 27, 2012
bioLytical recognizes the 10th Annual U.S. National LGBT Health Awareness Week, highlighting health issues and promoting testing
June 12, 2015
bioLytical grants an exclusive global license for its 60-second Ebola assay, facilitating worldwide access to rapid testing
October 29, 2011
bioLytical pledges support for the Second International Workshop on HIV Treatment as Prevention promoting global health initiatives
May 14, 2011
bioLytical applauds groundbreaking HIV/AIDS study recognizing the dedication of researchers worldwide to end HIV
December 2, 2011
INSTI is recognized on World AIDS Day as a pivotal innovation in HIV testing, contributing to the goal of zero new infections
April 12, 2013
The 60-second rapid HIV test expands its reach into U.S. point-of-care facilities improving accessibility and testing speed
March 10, 2012
bioLytical supports National Women and Girls HIV/AIDS Awareness Day, promoting awareness and testing for better health outcomes
October 9, 2011
The 60-second HIV test is making a significant impact in African countries, improving testing access and outcomes
November 21, 2013
bioLytical receives WHO prequalification for its INSTI HIV-1/2 Antibody Test affirming the quality and reliability of its HIV tests
February 15, 2012
bioLytical showcases the world's fastest HIV test to First Nations community healthcare providers to help increase testing access
September 22, 2012
AHF leads the nation with the first 1-minute HIV testing at The Abbey in West Hollywood promoting rapid testing and early diagnosis
December 2, 2012
NSTI breaks the Guinness World Record for HIV testing, setting a new standard for rapid and accurate HIV testing globally
July 24, 2012
The FDA grants a CLIA waiver to bioLytical's INSTI Rapid HIV Test, enhancing accessibility and simplifying testing procedures
October 26, 2011
bioLytical celebrates six years of groundbreaking progress in HIV testing and diagnostics, advancing global health
November 11, 2011
INSTI rapid tests play a crucial role in programs targeting HIV patients, boosting testing accessibility and support